- Exchange: Natl India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Indoco Remedies Ltd
+ Add to WatchlistINDR:IN
60.00 INR 1.45 2.36%As of 07:06:04 ET on 05/23/2013.
Snapshot for Indoco Remedies Ltd (INDR)
| Open: | 59.60 | Day's Range: | 59.35 - 62.85 | Volume: | 184,205 |
|---|---|---|---|---|---|
| Previous Close: | 61.45 | 52wk Range: | 51.40 - 83.00 | 1-Yr Rtn: | +4.01% |
Key Statistics for INDR
| Current P/E Ratio (ttm) | 16.8931 |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SENSEX | 1.0021 |
| Earnings Per Share (ttm) | 3.5517 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M INR) | 5,529.02 |
| Shares Outstanding (M) | 92.15 |
| 30 Day Average Volume | 38,185 |
| Price/Book (mrq) | 2.6816 |
| Price/Sale (ttm) | 2.1854 |
| Dividend Indicated Gross Yield | 1.83% |
| Cash Dividend (INR) | 1.1000 |
| Last Dividend | 07/20/2012 |
| 5 Year Dividend Growth | 4.88% |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for INDR
No data available
Company Profile & Key Executives for INDR
Indoco Remedies Limited researches and develops, manufactures, markets, and distributes pharmaceuticals. The Company's products include Analgesics/Antipyretics, Antacids, Anthelmintics, and Antiamoebics.
| Suresh Govind KareChairman/Managing Director | Jagdish B SalianVP:Legal/Secretary |
| Francis Xavier CoutinhoDirector:Marketing | Sundeep Vasant BambolkarDir:Finance & Operations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
INDR News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page